Adult patients with anxiety and/or depression meeting NHS Improving Access to Psychological Therapies (IAPT) recovery criteria at discharge of Step 2 care (guided-self-help) Mental and Behavioural Disorders
Conditions
Interventions
This is a mixed-methods study comprising three phases:
Phase 1 seeks to develop an in-depth understanding of barriers and facilitators influencing relapse following low intensity interventions for de
40-50 in total). Framework analysis will be used to inductively and deductively code interview transcripts.
Phase 2 aims to use the evidence from Phase 1 to co-produce, with multiple stakeholders, an
Sponsors
University of Manchester
Eligibility
Sex/Gender
All
Age
18 Years to 110 Years
Inclusion criteria
Inclusion criteria: Patients: 1. Aged 18 years or over 2. Received low intensity treatment in IAPT services located in Northern England and started with case-level depression and/or anxiety 3. Meet IAPT criteria for recovery in the last session attended. Following IAPT criteria, a person is considered to be at ‘caseness’ when their symptom score exceeds the accepted clinical threshold for the relevant measure of symptoms (PHQ-9 and GAD-7). A person moves to recovery if their symptoms were considered a clinical case at the start of their treatment and not a clinical case at the end of their treatment. IAPT services located in Northern England. Practitioners: Trainees or qualified psychological wellbeing practitioners delivering low intensity interventions in IAPT services located in Northern England. Key informants may include IAPT managers/service leads, policy-makers, commissioners, IAPT trainers, clinical academics, and national leads.
Exclusion criteria
Exclusion criteria: Individuals lacking the capacity to consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phase 1 aims to explore patients and stakeholders perspectives on barriers and facilitators influencing Recovery maintenance/relapse following low intensity interventions for depression/anxiety in IAPT using semi-structured interviews. Framework analysis will be used to inductively and deductively code interview transcripts. Phase 2 aims to co-produce, with patients and stakeholders an acceptable, evidence-based transdiagnostic relapse prevention toolkit for IAPT. An experienced based co-design framework, comprised of co-design workshops, one conducted with patients and one with mixed stakeholders will be conducted. The RAND/UCLA Appropriateness Methodology will be used. Phase 3 aims to review and finalise the developed toolkit with patients and stakeholders using a consensus approach. In addition, the best pathway for implementation will be identified to assist the uptake and facilitation of our transdiagnostic relapse prevention toolkit in IAPT services. All patient participants will be asked to complete the following questionnaires to describe the clinical sample and to identify maintenance of recovery or relapse at the point of their participation in the research: 1. Patient Health Questionnaire (PHQ-9) 2. Generalised Anxiety Disorder Scale (GAD-7) 3. Work and Social Adjustment Scale (WSAS) 4. Post-Treatment Experiences Questionnaire (optional) | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
England, United Kingdom
Outcome results
None listed